Related Experiment Videos
Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression
1Merck Research Laboratories, Merck and Co., West Point, PA 19422, USA. mark_kramer@merck.com
Neuropeptides
|October 26, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Arthralgia in midlife Singaporean women: the Integrated Women's Health Program (IWHP).
Climacteric : the journal of the International Menopause Society·2023
Gestational Serum Retinol Deficiency Is Associated with Enamel Hypoplasia.
Journal of dental research·2023
Excess mortality after hip fracture: fracture or pre-fall comorbidity?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study.
BJOG : an international journal of obstetrics and gynaecology·2020
Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
Human reproduction (Oxford, England)·2019
Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
A Systematic Review and a VigiBase Study of Accidental Clozapine Intoxications in Children and Adolescents.
Human psychopharmacology·2026
The interaction between paracetamol and ethanol during the early development of zebrafish.
Frontiers in pharmacology·2026
Popliteal Artery Aneurysm in a Young Intravenous Drug User: A Case Report.
Journal of orthopaedic case reports·2026
Neuroprotective Effects of Empagliflozin Against Methamphetamine-Induced Withdrawal Syndrome in Mice: Involvement of Bdnf, Tlr4, and JNK Signaling Pathways and Oxidative Stress Biomarkers.
Iranian journal of pharmaceutical research : IJPR·2026